← Back to series HSCI 180

Drugs and Society

Deeper dives into each HSCI 180 lesson, with Sarah and Kiffer

Each episode is meant for listening after the lesson. Sarah and Kiffer add perspective and critique, work through the questions students tend to find most difficult, and add further worked examples, including some that are harder than those in the lesson. Every page has the audio with a visual companion and captions, a summary, a list of chapters and a downloadable transcript.

Drugs, use and history

Lessons 01–02
L · 01
Drugs and Society: Concepts, Patterns of Use and LanguageSarah and Kiffer compare per-person and total harms, count standard drinks and DSM-5 criteria, test what surveys miss, and debate what to call deaths from the toxic drug supply.
Open deeper dive
L · 02
Drugs in History: How Substances Became Licit or IllicitSarah and Kiffer test historical drug figures, from prohibition-era drinking to 1920s conviction ratios, and debate the Le Dain Commission's 1972 choices on cannabis possession and supply.
Open deeper dive

Pharmacology and drug classes

Lessons 03–07
L · 03
How Drugs Work: Routes, Pharmacokinetics and PharmacodynamicsSarah and Kiffer unpack potency, half-life, accumulation, grapefruit interactions and expectancy, then debate how much a single safety ratio can say about a drug's danger.
Open deeper dive
L · 04
Alcohol and Other DepressantsSarah and Kiffer work through alcohol elimination, the uncertainty in blood alcohol estimates, benzodiazepine dependence and deprescribing, evidence on combined depressants, and Canada's drinking guidance.
Open deeper dive
L · 05
Opioids and the Toxic Unregulated Drug SupplySarah and Kiffer read opioid death statistics carefully, test potency comparisons, work the naloxone receptor-share model and debate how much of the crisis the toxic supply explains.
Open deeper dive
L · 06
Stimulants, Caffeine, Tobacco and VapingSarah and Kiffer read stimulant toxicology data, turn odds ratios and risk ratios into people, model nicotine across a day, and debate tobacco harm reduction.
Open deeper dive
L · 07
Cannabis, Psychedelics and New Psychoactive SubstancesSarah and Kiffer separate the amount of THC from its effect, rework attributable fractions for cannabis and psychosis, compare affinity with efficacy, and debate expert drug harm ratings.
Open deeper dive

Explaining use and addiction

Lessons 08–10
L · 08
The Neurobiology of Addiction: Reward, Learning and NeuroadaptationSarah and Kiffer test dopamine's teaching signal, model craving after withdrawal, unpack Ontario's online betting and the lower-risk gambling limit, and debate the brain disease model.
Open deeper dive
L · 09
Why Some People Develop Addiction and Others Do NotSarah and Kiffer show how heritability shifts with setting, test early drinking with a co-twin comparison, weigh Rat Park's replication record and debate the brain disease label.
Open deeper dive
L · 10
Why People Use Substances and Why Risks DifferSarah and Kiffer test what young people's reasons show, explain the prevention paradox with a hypothetical neighbourhood, read First Nations rate ratios by sex and debate dislocation theory.
Open deeper dive

Drug control and policy

Lessons 11–12
L · 11
Drug Control and the War on DrugsSarah and Kiffer test what enforcement did to drug prices, decompose representation ratios across the justice system, read the treaties closely and debate drug treatment courts and police diversion.
Open deeper dive
L · 12
Alternatives to Prohibition and an Integration of the CourseSarah and Kiffer test what decriminalization can change, read conflicting policy evaluations, check cannabis survey shares, apply the syndemic criteria and debate British Columbia's decision to end its exemption.
Open deeper dive